These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19208323)

  • 21. Totally drug-resistant and extremely drug-resistant tuberculosis: the same disease?
    Migliori GB; Centis R; D'Ambrosio L; Spanevello A; Borroni E; Cirillo DM; Sotgiu G
    Clin Infect Dis; 2012 May; 54(9):1379-80. PubMed ID: 22492321
    [No Abstract]   [Full Text] [Related]  

  • 22. Extensively drug-resistant tuberculosis in sub-Saharan Africa: an emerging public-health concern.
    Jones KD; Hesketh T; Yudkin J
    Trans R Soc Trop Med Hyg; 2008 Mar; 102(3):219-24. PubMed ID: 18243260
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phenotypic and genotypic analysis of multidrug-resistant tuberculosis in Ethiopia.
    Agonafir M; Lemma E; Wolde-Meskel D; Goshu S; Santhanam A; Girmachew F; Demissie D; Getahun M; Gebeyehu M; van Soolingen D
    Int J Tuberc Lung Dis; 2010 Oct; 14(10):1259-65. PubMed ID: 20843416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Extensively drug-resistant tuberculosis].
    Lange C; Grobusch MP; Wagner D
    Dtsch Med Wochenschr; 2008 Feb; 133(8):374-6. PubMed ID: 18270922
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Emergence of Low-level Delamanid and Bedaquiline Resistance During Extremely Drug-resistant Tuberculosis Treatment.
    Polsfuss S; Hofmann-Thiel S; Merker M; Krieger D; Niemann S; Rüssmann H; Schönfeld N; Hoffmann H; Kranzer K
    Clin Infect Dis; 2019 Sep; 69(7):1229-1231. PubMed ID: 30933266
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV coinfection among multidrug resistant and extensively drug resistant tuberculosis patients--a trend.
    Rajasekaran S; Chandrasekar C; Mahilmaran A; Kanakaraj K; Karthikeyan DS; Suriakumar J
    J Indian Med Assoc; 2009 May; 107(5):281-2, 284-6. PubMed ID: 19886382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical use of the meropenem-clavulanate combination for extensively drug-resistant tuberculosis.
    Payen MC; De Wit S; Martin C; Sergysels R; Muylle I; Van Laethem Y; Clumeck N
    Int J Tuberc Lung Dis; 2012 Apr; 16(4):558-60. PubMed ID: 22325421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ad fontes!
    Hoffner SE; Salfinger M
    Int J Tuberc Lung Dis; 2010 Mar; 14(3):260. PubMed ID: 20132612
    [No Abstract]   [Full Text] [Related]  

  • 29. Directly observed and standardized treatment in an era of extensively drug-resistant tuberculosis.
    Chang KC; Leung CC; Tam CM
    Clin Infect Dis; 2009 Jun; 48(11):1632-3; author reply 1633-4. PubMed ID: 19416026
    [No Abstract]   [Full Text] [Related]  

  • 30. XDR-TB in India : when will we heed the alarm?
    Udwadia ZF
    J Assoc Physicians India; 2008 Jun; 56():409-10. PubMed ID: 18822618
    [No Abstract]   [Full Text] [Related]  

  • 31. Long-term linezolid treatment in a young child with extensively drug-resistant tuberculosis.
    Schaaf HS; Willemse M; Donald PR
    Pediatr Infect Dis J; 2009 Aug; 28(8):748-50. PubMed ID: 19633523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extensively drug-resistant tuberculosis: "there must be some kind of way out of here".
    Cegielski JP
    Clin Infect Dis; 2010 May; 50 Suppl 3():S195-200. PubMed ID: 20397948
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification and development of 2,5-disubstituted oxadiazole as potential candidate for treatment of XDR and MDR tuberculosis.
    Bakal RL; Gattani SG
    Eur J Med Chem; 2012 Jan; 47(1):278-82. PubMed ID: 22088956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Death of a health care worker with nosocomial extensively drug-resistant tuberculosis in India.
    James P; Christopher DJ; Balamugesh T; Gupta R
    Int J Tuberc Lung Dis; 2009 Jun; 13(6):795-6. PubMed ID: 19460260
    [No Abstract]   [Full Text] [Related]  

  • 35. Extensively drug resistance (XDR) tb is not always fatal.
    Jain NK; Agnihotri SP; Sharma KK; Gupta S; Gupta P
    Indian J Tuberc; 2009 Jan; 56(1):48-50. PubMed ID: 19402272
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tuberculosis. Few mutations divide some drug-resistant TB strains.
    Koenig R
    Science; 2007 Nov; 318(5852):901-2. PubMed ID: 17991835
    [No Abstract]   [Full Text] [Related]  

  • 38. Extensively drug-resistant Mycobacterium tuberculosis: Charles Darwin would understand.
    Iseman MD
    Clin Infect Dis; 2007 Dec; 45(11):1415-6. PubMed ID: 17990221
    [No Abstract]   [Full Text] [Related]  

  • 39. New insight into extremely drug-resistant tuberculosis: using atomic force microscopy.
    Velayati AA; Farnia P; Merza MA; Zhavnerko GK; Tabarsi P; Titov LP; Ghanavei J; Farnia P; Setare M; Poleschuyk NN; Owlia P; Sheikolslami M; Ranjbar R; Masjedi MR
    Eur Respir J; 2010 Dec; 36(6):1490-3. PubMed ID: 21119210
    [No Abstract]   [Full Text] [Related]  

  • 40. The TB laboratory of the future: macrophage-based selection of XDR-TB therapeutics.
    Martins M; Viveiros M; Amaral L
    Future Microbiol; 2008 Apr; 3(2):135-44. PubMed ID: 18366334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.